Keyphrases
1-year-olds
9%
13-valent Pneumococcal Conjugate Vaccine (PCV13)
9%
Addition Strategy
9%
Case Fatality Rate
9%
Childhood Deaths
100%
Clinical Presentation
9%
Confidence Interval
9%
Conjugate Vaccine
9%
Death Cases
9%
Disease Case
27%
Disease Surveillance
9%
Disease-related
9%
Disease-specific Mortality
9%
Fatal Case
27%
Highly Effective
9%
Incidence Rate
9%
Invasive Pneumococcal Disease
100%
Meningitis
9%
Mortality Rate
9%
Neonate
9%
PCV7
9%
Pneumococcal Conjugate Vaccine
27%
Pneumococcal Vaccination
9%
Postal Survey
9%
Public Health England
9%
Risk Factors
9%
Vaccination Program
9%
Vaccine Introduction
27%
Vaccine Serotypes
9%
Vaccine-preventable Diseases
9%
Wales
100%
Medicine and Dentistry
Case Fatality Rate
9%
Child Death
100%
Conjugate Vaccine
9%
Disease Surveillance
9%
Fatality
27%
Meningitis
9%
Mortality Rate
9%
Neonate
9%
Pneumococcal Infection
100%
Pneumococcus Vaccine
45%
Public Health
9%
Serotype
36%
Pharmacology, Toxicology and Pharmaceutical Science
Case Fatality Rate
9%
Child Death
100%
Conjugate Vaccine
9%
Disease Surveillance
9%
Fatality
27%
Meningitis
9%
Mortality Rate
9%
Pneumococcal Infection
100%
Pneumococcus Vaccine
45%
Immunology and Microbiology
Case Fatality Rate
20%
Conjugate Vaccine
20%
Meningitis
20%
Mortality Rate
20%
Pneumococcal Vaccine
100%
Serotype
80%
Systemic-Onset Juvenile Idiopathic Arthritis
20%